BNR — Burning Rock Biotech Share News
0.000.00%
Last trade - 00:00- $164.08m
- $102.06m
- CNY539.57m
Burning Rock Biotech - BNR Schedules Q3 Earnings Release on Nov 30, 2023
Burning Rock Biotech - BNR and BI Achieved a Master Service Agreement
Brief: Burning Rock Biotech Receives Breakthrough Device Designation From China's NMPA
Burning Rock Biotech - BNR Received Breakthrough Device Designation
Brief: Burning Rock Received Breakthrough Device Designation From China's NMPA For Its Multi-Cancer Early Detection Test
Burning Rock Biotech - Study results published in the Cancer Cell
Brief: Burning Rock Biotech Q2 Gross Profit Rises 21.6%
Burning Rock Biotech - BNR Reports Second Quarter 2023 Financial Results
Brief: Burning Rock Says Qtrly Loss Per Share $0.18
Burning Rock Biotech - BNR Schedules Earnings Release on August 31, 2023
Burning Rock Biotech - Announces Resignation and Appointment of Directors
Burning Rock Biotech - Published in the New England Journal of Medicine
Brief: Burning Rock Biotech Reiterates 2023 FY Revenue Guidance Of About 20% Growth Over 2022
Burning Rock Biotech - Burning Rock Reports 1st Quarter Financial Results
Brief: Burning Rock Reports First Quarter 2023 Financial Results
Burning Rock Biotech - BNR Schedules Q1 Earnings Release on May 30, 2023
Burning Rock Biotech - BNR Publishes 2022 Annual Report on Form 20-F
Brief: Burning Rock Says Qtrly Loss Per Share For Class A And Class B Ordinary Shares $0.31
Burning Rock Biotech - Burning Rock Reports Q4 and Full Year 2022 Results